Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Return on Sales (2016 - 2025)

OptimizeRx (OPRX) has disclosed Return on Sales for 16 consecutive years, with 0.16% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 16.0% to 0.16% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.05% through Dec 2025, up 27.0% year-over-year, with the annual reading at 0.05% for FY2025, 27.0% up from the prior year.
  • Return on Sales hit 0.16% in Q4 2025 for OptimizeRx, up from 0.03% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.16% in Q4 2025 to a low of 0.49% in Q1 2023.
  • Historically, Return on Sales has averaged 0.15% across 5 years, with a median of 0.14% in 2023.
  • Biggest five-year swings in Return on Sales: tumbled -40bps in 2023 and later soared 46bps in 2025.
  • Year by year, Return on Sales stood at 0.03% in 2021, then plummeted by -154bps to 0.02% in 2022, then crashed by -2396bps to 0.41% in 2023, then skyrocketed by 99bps to 0.0% in 2024, then skyrocketed by 6551bps to 0.16% in 2025.
  • Business Quant data shows Return on Sales for OPRX at 0.16% in Q4 2025, 0.03% in Q3 2025, and 0.05% in Q2 2025.